ESR1 and neoplasm: Another study by Jacene et al. involving serial imaging in estrogen receptor-positive postmenopausal patients undergoing selective AR modulation (SARM) therapy with GTx-024 demonstrated a greater reduction in tumor uptake in patients experiencing clinical benefit, although the difference was not statistically significant and the sample size was limited (n = 11) [186].